Document Detail


Prevention and treatment of cardioembolic stroke: a case study.
MedLine Citation:
PMID:  20156003     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ischemic stroke is a medical emergency that requires immediate evaluation and treatment. During the acute phase following stroke, the goal of therapy is reperfusion of the ischemic area with thrombolytic therapy. Blood pressure (BP) goals during the first 24 hours depend on eligibility for tissue plasminogen activator (tPA). Following the acute phase, therapy is directed at prevention of recurrent stroke with antithrombotics and control of ischemic-stroke risk factors. This is a case of a 79-year-old female with newly diagnosed atrial fibrillation who was inappropriately started on aspirin for anticoagulation despite her high risk for stroke. She subsequently suffered a cardioembolic stroke. The patient was not a candidate for tPA because of the inability to determine when symptom onset occurred. Supportive care focused on BP and glycemic control as well as venous thromboembolism prophylaxis. Secondary prevention of stroke for this patient included treatment of hypertension, diabetes, and hypercholesterolemia as well as initiation of warfarin.
Authors:
Jorie A Glick; Gretchen M Brophy
Related Documents :
7956383 - Surgical management in patients with coexistent coronary and cerebrovascular disease. l...
23642493 - Clinical outcomes of the realize adjustable gastric band-c at 2 years in a united state...
20338343 - Long-term results after repair of complete atrioventricular septal defect with two-patc...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists     Volume:  24     ISSN:  0888-5109     ISO Abbreviation:  Consult Pharm     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-02-16     Completed Date:  2010-03-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9013983     Medline TA:  Consult Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  903-9     Citation Subset:  IM    
Affiliation:
Virginia Commonwealth University Health System/Medical College of Virginia Hospitals, Richmond, VA 23298-0533, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aspirin / therapeutic use
Atrial Fibrillation / complications*,  drug therapy
Embolism / drug therapy,  etiology,  prevention & control
Female
Fibrinolytic Agents / therapeutic use*
Humans
Risk Factors
Stroke / drug therapy,  etiology,  prevention & control*
Venous Thromboembolism / prevention & control
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A treatment algorithm for neuropathic pain: an update.
Next Document:  Alternative ways to resolve contract disputes: implications for pharmacists, facilities, and patient...